Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 5, 2023
Abstract
Toxic
exposures
to
heavy
metals,
such
as
iron
(Fe)
and
manganese
(Mn),
can
result
in
long-range
neurological
diseases
are
therefore
of
significant
environmental
medical
concerns.
We
have
previously
reported
that
damage
neuroblastoma-derived
dopaminergic
cells
(SH-SY5Y)
by
both
Fe
Mn
could
be
prevented
pre-treatment
with
nicotine.
Moreover,
butyrate,
a
short
chain
fatty
acid
(SCFA)
provided
protection
against
salsolinol,
selective
toxin,
the
same
cell
line.
Here,
we
broadened
investigation
determine
whether
butyrate
might
also
protect
and/or
Mn,
whether,
if
combined
nicotine,
an
additive
or
synergistic
effect
observed.
Both
nicotine
concentration-dependently
blocked
toxicities.
The
ineffective
concentrations
when
combined,
full
Mn.
effects
but
not
mecamylamine,
non-selective
nicotinic
antagonist.
On
other
hand,
beta-hydroxy
acid-3
receptor
These
results
only
provide
further
support
for
neuroprotective
indicate
distinct
mechanisms
action
each
one.
Furthermore,
potential
utility
combination
metal
toxicities
is
suggested.
Cells,
Journal Year:
2024,
Volume and Issue:
13(6), P. 474 - 474
Published: March 7, 2024
Parkinson’s
disease
(PD)
is
a
progressive
neurodegenerative
characterized
by
resting
tremor,
bradykinesia,
rigidity,
and
postural
instability
that
also
includes
non-motor
symptoms
such
as
mood
dysregulation.
Dopamine
(DA)
the
primary
neurotransmitter
involved
in
this
disease,
but
cholinergic
imbalance
has
been
implicated.
Current
intervention
PD
focused
on
replenishing
central
DA,
which
provides
remarkable
temporary
symptomatic
relief
does
not
address
neuronal
loss
progression
of
disease.
It
well
established
nicotinic
receptors
(nAChRs)
can
regulate
DA
release
nicotine
itself
may
have
neuroprotective
effects.
Recent
studies
identified
nAChRs
nonneuronal
cell
types,
including
glial
cells,
where
they
inflammatory
responses.
Given
crucial
role
neuroinflammation
dopaminergic
degeneration
involvement
microglia
astrocytes
response,
provide
novel
therapeutic
target
prevention
and/or
treatment
PD.
In
review,
following
brief
discussion
PD,
we
focus
cells
and,
specifically,
their
pathology
treatment.
Analytical Chemistry,
Journal Year:
2022,
Volume and Issue:
94(3), P. 1867 - 1873
Published: Jan. 13, 2022
Simultaneous
enantiomeric
analysis
is
especially
important
for
medicine,
food
security,
and
life
science.
Chiral
of
multicomponent
amine
mixtures
still
faces
many
challenges.
Here,
our
work
demonstrates
the
first
time
that
a
novel
chiral
derivatizing
agent
CDApro
based
on
trans-4-fluoro-l-proline
(trans4Fpro)
has
been
successfully
used
rapid
simultaneous
22
nonamino
acid
(non-AA)
amines,
l/d-AAs,
or
mirror-image
dipeptides
in
mixture,
as
well
amines
with
centers
several
carbons
remote
to
amino
group.
Furthermore,
determination
purity
quantification
can
be
made
using
CDApro,
which
serves
robust
powerful
reagent
differentiation
amines.
Cells,
Journal Year:
2023,
Volume and Issue:
12(16), P. 2051 - 2051
Published: Aug. 11, 2023
The
cholinergic
system
plays
an
essential
role
in
brain
development,
physiology,
and
pathophysiology.
Herein,
we
review
how
specific
alterations
this
system,
through
genetic
mutations
or
abnormal
receptor
function,
can
lead
to
aberrant
neural
circuitry
that
triggers
disease.
focuses
on
the
nicotinic
acetylcholine
(nAChR)
its
addiction
neurodegenerative
neuropsychiatric
diseases
epilepsy.
Cholinergic
dysfunction
is
associated
with
inflammatory
processes
mainly
involvement
of
α7
nAChRs
expressed
peripheral
immune
cells.
Evidence
suggests
these
neuroinflammatory
trigger
aggravate
pathological
states.
We
discuss
preclinical
evidence
demonstrating
therapeutic
potential
nAChR
ligands
Alzheimer
disease,
Parkinson
schizophrenia
spectrum
disorders,
autosomal
dominant
sleep-related
hypermotor
PubMed
Google
Scholar
bibliographic
databases
were
searched
keywords
indicated
below.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 2, 2023
Introduction:
Nicotine
(Nic)
has
previously
been
proven
to
reduce
neurodegeneration
in
the
models
of
Parkinson's
disease
(PD).
The
present
study
is
intended
investigate
detailed
mechanisms
related
potential
neuroprotective
effects
Nic
vivo.
Methods:
We
established
a
PD
model
using
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-induced
C57BL6
mice
(25
mg/kg/d,
5
d,
i.p.)
neuropharmacological
modulation
pretreatment
(2.5
i.p.,
30
min
before
MPTP
injection)
from
perspectives
neurobehavioral
assessment,
pathological
alterations,
microglial
cell
inflammation
and
MAPK
signaling
pathways
specific
brain
regions.
Results:
open
field
test,
elevated
plus
maze,
rotarod
traction
test
suggested
that
could
significantly
improve
MPTP-induced
motor
impairment
had
an
anxiolytic
effect.
was
found
neuroapoptosis,
enhance
tyrosine
hydroxylase
activity,
accumulation
phosphorylated
α-synuclein
substantia
nigra
striatal
regions
by
TUNEL
immunohistochemical
assays.
Immuno-fluorescent
method
for
labeling
Iba1
CD68
indicated
remarkably
alleviates
activation
microglia
which
represents
M1
polarization
state
under
stimulation.
No
significant
difference
expression
p38/MAPK
pathway
nigrostriatal
regions,
while
inhibit
p-JNK/JNK
ratio
increase
declined
p-ERK/ERK
MPTP-exposed
brains,
further
confirmed
CYP2A5
inhibitor
decline
metabolic
activity
Nic.
Discussion:
molecular
mechanism
exerts
its
against
may
be
achieved
regulating
JNK
ERK
nigra-striatum
Neural Regeneration Research,
Journal Year:
2023,
Volume and Issue:
19(3), P. 529 - 535
Published: July 28, 2023
Abstract
The
positive
effect
of
levodopa
in
the
treatment
Parkinson’s
disease,
although
it
is
limited
time
and
has
severe
side
effects,
encouraged
scientific
community
to
look
for
new
drugs
that
can
stop
neurodegenerative
process
or
even
regenerate
neuromelanin-containing
dopaminergic
nigrostriatal
neurons.
Successful
preclinical
studies
with
coenzyme
Q10,
mitoquinone,
isradipine,
nilotinib,
TCH346,
neurturin,
zonisamide,
deferiprone,
prasinezumab,
cinpanemab
prompted
clinical
trials.
However,
these
failed
after
more
than
50
years
continues
be
key
drug
despite
its
effects
4–6
chronic
treatment.
lack
translated
successful
results
obtained
investigations
based
on
use
neurotoxins
do
not
exist
human
body
as
disease
a
big
problem.
In
our
opinion,
cause
failures
lies
experimental
animal
models
involving
body,
such
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
6-hydroxydopamine,
induce
very
fast,
massive
expansive
process,
which
contrasts
extremely
slow
one
exceedingly
progress
neurons
idiopathic
patients
due
(i)
degenerative
model
neurotoxic
an
endogenous
neurotoxin
affects
single
neuron,
(ii)
event
(iii)
fact
triggers
produced
inside
fits
this
neuron
at
aminochrome,
since
generated
within
neurons,
does
all
mechanisms
involved
disease.
conclusion,
hypothesis
corresponds
single-neuron
neurodegeneration
model,
we
must
search
molecules
increase
expression
neuroprotective
enzymes
DT-diaphorase
glutathione
transferase
M2-2.
It
been
observed
activation
Kelch-like
ECH-associated
protein
1/nuclear
factor
(erythroid-derived
2)-like
2
pathway
associated
transcriptional
genes.
Separations,
Journal Year:
2022,
Volume and Issue:
9(8), P. 224 - 224
Published: Aug. 17, 2022
L-dopa
is
a
precursor
of
dopamine
used
as
the
most
effective
symptomatic
drug
treatment
for
Parkinson’s
disease.
Most
isolated
either
synthesized
chemically
or
from
natural
sources,
but
only
some
plants
belonging
to
Fabaceae
family
contain
significant
amounts
L-dopa.
Due
its
low
stability,
unambiguous
determination
in
plant
matrices
requires
appropriate
technologies.
Several
analytical
methods
have
been
developed
different
plants.
The
quantification
are
mainly
based
on
capillary
electrophoresis
chromatographic
methods,
i.e.,
high-performance
liquid
chromatography
(HPLC),
coupled
ultraviolet-visible
mass
spectrometric
detection.
HPLC
often
used.
This
paper
aims
give
information
latest
developments
chemical
study
L-dopa,
emphasizing
extraction,
separation
and
characterization
this
compound
by
chromatographic,
electrochemical
spectral
techniques.
can
help
select
best
possible
strategy
determining
using
advanced
methods.